Wei22 compared the immunohistochemistry scores of EGFR, HER2, and HER3 between primary CRC and lymph node metastases, and found moderate to high correlation (EGFR: 69.6%; HER2: 96.4%; HER3: 83.7%). This evidence concerns the gene ERBB3 and colorectal carcinoma.